Press Releases

Strength across the company's largest franchises, new growth platforms, and recent portfolio investments support the long-term growth trajectoryGALWAY, Ireland, Sept. 1, 2026 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2027 (FY27), which ended July 31, 2026.Key HighlightsRevenue of $9.8 billion, increased 13.7% as reported and 13.7% organic, roughly 200 basis points above guidance midpointGAAP diluted EPS of $1.14; non-GAAP diluted EPS of $1.45, ahead of guidanceRaising FY27 organic revenue growth guidance 50 basis points to 7.25% to 7.75%, and FY27 diluted non-GAAP EPS guidance to th

Strong start to fiscal year with net sales of $843 million growing 17% as reported and 16% organicU.S. net sales growth accelerated to 13%; continued robust international net sales growth of 18% as reported, 17% organicAdvanced global pipeline ahead of schedule with FDA submission for MiniMed Fit™, CE Mark for MiniMed Flex™, Vivera™ FCL U.S. pivotal trial enrollment completion, and IDE approval for next-gen extended wear MiniMed sensorRaises fiscal year 2027 organic revenue growth guidanceNORTHRIDGE, Calif., Sept. 1, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today reported financial results for its first quarter (Q1) of fiscal year 2027 (FY27), ended

eCential Robotics platform to join Enovis' enabling technology portfolio.GRENOBLE, France and FRANKLIN, Tenn., Sept. 1, 2026 /PRNewswire/ -- eCential Robotics, a leading developer of enabling technologies and surgical robotics, today announced that Enovis™ Corporation (NYSE:ENOV) has entered a binding offer to acquire the company. Following completion of the information and consultation process with eCential Robotics' works council in accordance with French law, the parties expect to enter into a definitive purchase agreement. The transaction is expected to close during the fourth quarter of 2026, subject to regulatory approval

Partnership expands Medtronic's robotic-assisted surgery portfolio to expand access globally and gives surgeons and health systems more choice and flexibility$700 million investment includes rights to distribute Cornerstone Robotics' Sentire™ surgical system in select markets outside the U.S.Sentire will be a strong complement to Medtronic's Hugo™ robotic-assisted surgery (RAS) system, creating a unique portfolio of robotic solutionsGALWAY, Ireland, Sept. 1, 2026 /PRNewswire/ -- Medtronic, a global leader in healthcare technology, today announced a strategic partnership with Cornerstone Robotics, an innovative surgical robotics company committed to advancing minimally invasive surgery and im

– New C-Suite Role and Appointment Underscore Commitment to Building a Strong, Commercial-Ready Data Ecosystem, in Preparation for Potential NDA Submission and Commercialization –NEW YORK, Sept. 1, 2026 /PRNewswire/ -- Immunic, Inc. (NASDAQ:IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced the appointment of Chitrang Davé as Chief Data and Digital Officer (CDDO), effective today. Mr. Davé will report directly to Chief Executive Officer Erik Lundgren and will serve as a member of the executive leadership team.In this newly created C-suite role, Mr. Davé will establish and lead Immunic's enterprise-wide data sy

GALWAY, Ireland and REHOVOT, Israel, Sept. 1, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, and Pi-Cardia Ltd., a pioneer in leaflet modification technologies for structural heart disease, today announced a strategic investment by Medtronic in Pi-Cardia Ltd. With a focus on addressing the evolving needs of increasingly complex transcatheter aortic valve replacement (TAVR) patients and procedures, Medtronic secures an option for strengthening its structural heart portfolio through this strategic investment, supporting the next generation of innovation.  Pi-Cardia's ShortCut™ device is t

Two directional drill holes, designed to test the Ramp Zone at depth, inadvertently encountered a new high-grade, gold dominant zone of mineralization before reaching the intended target depth and outlined a 100-meter northern extension to the Apollo breccia body with results as follows:141.40m @ 4.88 g/t AuEq from 924 meters below surface including 38.00m @ 15.46 g/t AuEq (APC172-D2)97.15m @ 1.06 g/t AuEq from 929 meters below surface (APC172-D1)Holes APC172-D1 and APC172-D2 also represent the deepest holes drilled to date on the northern side of the main Apollo breccia body. These intercepts have resulted in a 170-meter vertical extension to the Apollo system. Mineralization on the norther

Fiscal 2026 highlights:Science Based Targets initiative validates Bio-Techne's Scope 1, 2 and 3 greenhouse gas reduction targetsMarket-based Scope 1 and 2 emissions reduced 49% year-over-yearMore than half of the company's electricity consumption now comes from renewable sourcesFirst comprehensive Scope 3 emissions inventory completedMINNEAPOLIS, Sept. 1, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH), a global provider of life science tools, reagents and diagnostic products, today announced significant progress toward its climate and sustainability objectives, including validation of its greenhouse gas reduction targets by the Science Based Targets initiative (SBTi) and substanti

Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the 2026 Cantor Global Healthcare Conference on September 9, 2026 and will participate in a fireside chat at 3:20pm ET and a panel entitled "PSYCH! Accessing The New Wave of Psychedelics" at 4:30pm ET. A live audio webcast of the fireside chat will be accessible from the "Events" page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways We believe mental health patients deserve the possibility of a better

Newport Beach CA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Bimergen Energy (NYSE:BESS), a U.S. energy infrastructure developer, owner and operator, is pleased to announce its participation at the upcoming Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, taking place September 9-10, 2026, in New York City. Bob Brilon Co-CEO will be delivering an investor presentation and participating in scheduled 1-on-1 meetings with investors. Date: Thursday, September 10, 2026Time: 2:10 PM ETLocation: The Westin New York Grand Central, 212 E 42nd St, New York, NYPresenter: Bob Brilon Co-CEOMore info: https://moodycapital.com/conference/ About the Moody Capital Solutions 2026 Disrupt

Anchorage, Alaska, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Nova Minerals Corp ("Nova Minerals" or the "Company") (NYSE:NVA, ASX: NVA)) is pleased to report that geotechnical drilling is underway and that the Alaska Industrial Development and Export Authority ("AIDEA") has authorized up to $25 million in additional funding to advance the West Susitna Access Road. The proposed year-round road will provide a critical transportation link between the Company’s Estelle Gold and Critical Minerals Project and its planned Port MacKenzie antimony refinery. Highlights The West Susitna Access Road is a transformative 78.5-mile, year-round all-weather road that will support critical mineral development in

Enhances Enovis’ enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room. Creates a robotics center of excellence in Grenoble, France, a talent rich medical technology hub.   Dallas, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- – Enovis™ Corporation (NYSE:ENOV), an innovation-driven medical technology company, announced today that it has entered into a binding offer to acquire eCential Robotics, a leading developer of enabling technologies and surgical robotics. The acquisition expands the ASTRA™ enabling technology platform with robotic automation capabilities, creating a more compreh

Positive Full-Year Same-Store Sales Growth, Including 3.0% at Supercuts Continued Profitability and Positive Cash Flow Support On-Going Efforts to Advance Long-term Growth Initiatives Regis Corporation (NASDAQGM:RGS), a leader in the haircare industry, today announced financial results for the fourth fiscal quarter and full year ended June 30, 2026. Susan Lintonsmith, Regis Corporation's President and Chief Executive Officer, commented, "Fiscal 2026 marked a year of continued progress toward strengthening the foundation of our business. We delivered revenue of $224.5 million, operating income of $24.4 million, Adjusted EBITDA of $32.8 million, and generated more than $13 million in ca

A new Q2 2026 report highlights critical workplace mental health trends, revealing sixty per cent of Canadian workers don't understand their retirement benefits, while 27 percent feel unsafe disclosing mental health issues to managers.Quick Facts:Cost of living is the top financial stressor for 63 percent of workers, dwarfing those concerned about retirement savings (12 percent) and emergency savings (8 percent)More than half (60 percent) of workers in Canada don't fully understand the retirement or savings plan they pay intoThe Index reveals a stark link between employee financial wellbeing and overall productivity, as one in five workers in Canada say money stress is negatively affecting t

LAS VEGAS, Sept. 1, 2026 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE:GPUS), an artificial intelligence ("AI") data center company anchored by Bitcoin ("Hyperscale Data" or the "Company"), today announced that, as of August 30, 2026, it held 214.9701 Bitcoin representing an aggregate value of approximately $16.7 million based on the Bitcoin closing price of $77,668 on August 30, 2026. In aggregate, the Company's wholly owned subsidiaries, Sentinum, Inc. ("Sentinum") and Ault Capital Group, Inc. ("ACG"), held 214.9701 Bitcoin as of August 30, 2026. During the week ended August 30, 2026, the Company sold approximately 65 Bitcoin i

RANCHO CUCAMONGA, Calif., Sept. 1, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, will be presenting at the Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8th, 2026, at 4:30 pm ET. For access to the webcast, visit Amphastar Pharmaceuticals' website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation. About Amphastar Pharmaceuticals, Inc.Amphastar is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing

SOUTH SAN FRANCISCO, Calif., Sept. 1, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced its upcoming Investor R&D Day in London and participation in September 2026 investor conferences. IDEAYA Biosciences Investor R&D Day in London, United KingdomMonday, November 16th, 2026, at 5:00 PM GMTIDEAYA management will discuss the company's MTAP/CDKN2A and KRAS development strategy in pancreatic cancer, including new preclinical data and rational combination strategies designed to address tumor heterogen

BeOne Medicines Ltd. (NASDAQ:ONC, HKEX: 06160, SSE: 688235)), a global oncology company, today announced it will participate in the Morgan Stanley Annual Global Healthcare Conference on September 14, 2026, with a fireside chat at 11:30 a.m. EDT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901309669/en/BeOne Medicines' flagship clinical and commercial-stage manufacturing and research and development facility in Hopewell, N.J. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. An archived webcast will be available on the Company’s website. Ab

Signatera demonstrates 100% positive predictive value for treatment response assessment, detects recurrence months earlier than imaging, and supports precise, individualized lymphoma management through serial ctDNA monitoring Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of new data in Blood Neoplasia, validating the prognostic and predictive value of Signatera in patients with both newly diagnosed and relapsed/refractory (R/R) lymphoma. PET/CT scans serve as the standard tool for assessing treatment response in lymphoma, but their performance is limited, with positive predictive value (PPV) reported as low as 50% an

ACI will incorporate Cranium Ventures’ microservices-based card switching framework into ACI Connetic for Cards. ACI Worldwide (NASDAQ:ACIW), an original innovator in global payments technology, today announced it has entered into a definitive agreement to acquire Cranium Ventures, a privately held developer of cloud-native card payment switching technology. The technology will be added to ACI Connetic for Cards, which ACI launched in March 2026. ACI Connetic is the platform behind ACI’s intelligent payments orchestration strategy, introduced in 2025 as the industry’s first unified cloud-native platform bringing account-to-account payments, card payments and AI-powered fraud prevention